Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,060 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.
Uemura S, Nishimura N, Hasegawa D, Shono A, Sakaguchi K, Matsumoto H, Nakamachi Y, Saegusa J, Yokoi T, Tahara T, Tamura A, Yamamoto N, Saito A, Kozaki A, Kishimoto K, Ishida T, Nino N, Takafuji S, Mori T, Iijima K, Kosaka Y. Uemura S, et al. Among authors: matsumoto h. Int J Hematol. 2018 May;107(5):604-609. doi: 10.1007/s12185-017-2371-5. Epub 2017 Nov 24. Int J Hematol. 2018. PMID: 29177615
Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection.
Ohyama S, Morioka I, Fukushima S, Yamana K, Nishida K, Iwatani S, Fujioka K, Matsumoto H, Imanishi T, Nakamachi Y, Deguchi M, Tanimura K, Iijima K, Yamada H. Ohyama S, et al. Among authors: matsumoto h. Int J Mol Sci. 2019 Mar 19;20(6):1388. doi: 10.3390/ijms20061388. Int J Mol Sci. 2019. PMID: 30893926 Free PMC article.
Prediction of poor neurological development in patients with symptomatic congenital cytomegalovirus diseases after oral valganciclovir treatment.
Fukushima S, Morioka I, Ohyama S, Nishida K, Iwatani S, Fujioka K, Mandai T, Matsumoto H, Nakamachi Y, Deguchi M, Tanimura K, Iijima K, Yamada H. Fukushima S, et al. Among authors: matsumoto h. Brain Dev. 2019 Oct;41(9):743-750. doi: 10.1016/j.braindev.2019.04.016. Epub 2019 May 7. Brain Dev. 2019. PMID: 31072632
An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells.
Mizutani Y, Inase A, Maimaitili Y, Miyata Y, Kitao A, Matsumoto H, Kawaguchi K, Higashime A, Goto H, Kurata K, Yakushijin K, Minami H, Matsuoka H. Mizutani Y, et al. Among authors: matsumoto h. Int J Hematol. 2019 Oct;110(4):490-499. doi: 10.1007/s12185-019-02701-2. Epub 2019 Jul 8. Int J Hematol. 2019. PMID: 31286402
Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dubé syndrome.
Kurata K, Matsumoto H, Jimbo N, Yakushijin K, Yamamoto K, Ito M, Nakamachi Y, Matsuoka H, Saegusa J, Seyama K, Itoh T, Minami H. Kurata K, et al. Among authors: matsumoto h. Int J Hematol. 2020 Dec;112(6):864-870. doi: 10.1007/s12185-020-02970-2. Epub 2020 Aug 12. Int J Hematol. 2020. PMID: 32789566
5,060 results